In 1972, an extension of Medicare was passed to cover the cost associated with dialysis treatments for any US citizen who was suffering from End Stage Renal Disease. This provision along with the rise of Type II diabetes and hypertension as more common ailments has helped to set the stage for the rise of private specialty providers of dialysis treatment. The two largest in the US are DaVita and Fresenius.